GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TOWA Pharmaceutical Co Ltd (TSE:4553) » Definitions » Cyclically Adjusted Revenue per Share

TOWA Pharmaceutical Co (TSE:4553) Cyclically Adjusted Revenue per Share : 円2,617.68 (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is TOWA Pharmaceutical Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

TOWA Pharmaceutical Co's adjusted revenue per share for the three months ended in Dec. 2023 was 円1,237.916. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円2,617.68 for the trailing ten years ended in Dec. 2023.

During the past 12 months, TOWA Pharmaceutical Co's average Cyclically Adjusted Revenue Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of TOWA Pharmaceutical Co was 15.70% per year. The lowest was 9.00% per year. And the median was 12.00% per year.

As of today (2024-06-06), TOWA Pharmaceutical Co's current stock price is 円2908.00. TOWA Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was 円2,617.68. TOWA Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is 1.11.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of TOWA Pharmaceutical Co was 2.34. The lowest was 0.72. And the median was 1.49.


TOWA Pharmaceutical Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for TOWA Pharmaceutical Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TOWA Pharmaceutical Co Cyclically Adjusted Revenue per Share Chart

TOWA Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,498.76 1,698.51 1,949.88 2,319.58 -

TOWA Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,319.58 2,416.32 2,516.19 2,617.68 -

Competitive Comparison of TOWA Pharmaceutical Co's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, TOWA Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TOWA Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TOWA Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where TOWA Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.



TOWA Pharmaceutical Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, TOWA Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=1237.916/106.8000*106.8000
=1,237.916

Current CPI (Dec. 2023) = 106.8000.

TOWA Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 316.283 95.700 352.968
201406 323.344 98.000 352.379
201409 333.072 98.500 361.138
201412 384.164 97.900 419.088
201503 361.185 97.900 394.020
201506 381.092 98.400 413.624
201509 387.016 98.500 419.628
201512 413.953 98.100 450.664
201603 391.808 97.900 427.427
201606 410.027 98.100 446.390
201609 413.420 98.000 450.543
201612 471.052 98.400 511.264
201703 398.806 98.100 434.174
201706 423.161 98.500 458.818
201709 416.925 98.800 450.684
201712 483.364 99.400 519.349
201803 431.963 99.200 465.057
201806 479.283 99.200 516.002
201809 444.396 99.900 475.090
201812 548.104 99.700 587.136
201903 504.108 99.700 540.007
201906 534.088 99.800 571.549
201909 506.342 100.100 540.233
201912 546.188 100.500 580.427
202003 488.336 100.300 519.983
202006 712.112 99.900 761.297
202009 746.536 99.900 798.099
202012 807.007 99.300 867.959
202103 732.220 99.900 782.794
202106 852.962 99.500 915.541
202109 781.352 100.100 833.650
202112 861.631 100.100 919.303
202203 794.621 101.100 839.422
202206 901.490 101.800 945.768
202209 916.826 103.100 949.729
202212 1,013.876 104.100 1,040.172
202303 1,390.720 104.400 1,422.691
202306 1,108.204 105.200 1,125.059
202309 1,073.666 106.200 1,079.732
202312 1,237.916 106.800 1,237.916

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


TOWA Pharmaceutical Co  (TSE:4553) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

TOWA Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=2908.00/2617.68
=1.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of TOWA Pharmaceutical Co was 2.34. The lowest was 0.72. And the median was 1.49.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


TOWA Pharmaceutical Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of TOWA Pharmaceutical Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


TOWA Pharmaceutical Co (TSE:4553) Business Description

Traded in Other Exchanges
Address
2-11, Shinbashi-cho, Kadoma, Osaka, JPN, 571-8580
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.

TOWA Pharmaceutical Co (TSE:4553) Headlines

No Headlines